Skip to content

Adjusted dialysis settings in the intensive care

Equal dose altered prescription: lowering convective flow in CVVHDF - Lowering convective flow in CVVHDF

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON57838
Enrollment
90
Registered
2025-02-07
Start date
2025-09-15
Completion date
Unknown
Last updated
2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute kidney injury, acute on chronic kidney injury, chronic kidney disease

Interventions

The intervention group will receive CVVHDF with a distribution between convective and diffusive flow of approximately 50%/50%. The control group will receive CVVHDF (distribution between convective an

Sponsors

Universitair Medisch Centrum Groningen
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: In order to be eligible to participate in this study, a participant must meet all of the following criteria:18 years or older CRRT indicationAcute or (acute on) chronic renal failure

Exclusion criteria

Exclusion criteria: A potential participant who meets any of the following criteria will be excluded from participation in this study:CRRT for intoxication(Risk of/ probable) elevated intracranial pressureSevere hyponatremia < 125 mmol/lSevere hypernatremia >155 mmol/lPregnancy 

Design outcomes

Primary

MeasureTime frame
The main study endpoint is the CRRT circuit survival time. 

Secondary

MeasureTime frame
Secondary endpoints are the rate of metabolic correction, CRRT treatment duration in hours and the circuit performance. Metabolic correction will be studied by evaluating the courses of potassium, phosphate, pH, HCO3- and urea. Filter performance will be studied by evaluating the clearance of beta-2 microglobulin and the ratio of urea in the effluent fluid and in the patients plasma (4). 

Countries

Netherlands

Contacts

Public ContactM. Volbeda

Universitair Medisch Centrum Groningen

m.volbeda@umcg.nl0625650607

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)